Merk reported $236.7M in Selling and Administration Expenses for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 236.5M 9M
Amgen AMGN:US $ 129.5M 2.1M
AstraZeneca AZN:LN 2.27B 9M
Astrazeneca AZN:US 2.27B 9M
Biogen BIIB:US $ 57.31M 3.2M
Bristol Myers Squibb BMY:US $ 162.8M 5.4M
Eli Lilly And LLY:US $ 144.86M 10.1M
Endo International Ordinary Shares ENDP:US 182.26M 9M
Gilead Sciences GILD:US $ 123.9M 16.3M
GlaxoSmithKline GSK:LN 253M 25.6M
Glaxosmithkline GSK:US 2.48B 53M
Horizon Pharma HZNP:US 226.16M 3.83M
Intercept Pharmaceuticals ICPT:US $ 9.34M 519.8K
JAZZ PHA JAZZ:US 207.26M 15.85M
Johnson & Johnson JNJ:US $ 5.43B 438M
Medtronic MDT:US 2.37B 60M
Merk MRK:US $ 236.7M 17.7M
Novartis NOVN:VX 3.32B 137M
Novartis NVS:US 3.41B 94M
Pacira Pharmaceuticals PCRX:US $ 4.33M 143.8K
Perrigo Ordinary Shares PRGO:US 280.9M 13.5M
Pfizer PFE:US $ 280.9M 6.5M
Regeneron Pharmaceuticals REGN:US $ 34.83M 1.9M
Revance Therapeutics RVNC:US $ 29.61M 8.38M
Teva Pharmaceutical Industries TEVA:US 853M 30M
United Therapeutics UTHR:US $ 10.59M 1.29M
Zoetis ZTS:US $ 39.3M 400K